LifeMD GLP-1 Program: What the Subscription Includes

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub, your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education.

This is an independent editorial review. PlexusDx has no commercial relationship with LifeMD or its parent company, and no affiliate links or compensation are involved. LifeMD is one of many GLP-1 telehealth programs; the sections below describe how its GLP-1 offering is structured as of April 2026 without recommending a purchase.

LifeMD's subscription approach to GLP-1 care

LifeMD runs a subscription-telehealth model. A licensed provider evaluates you remotely and, where appropriate, issues a prescription filled at a retail pharmacy for FDA-approved brand products or at a 503A compounding pharmacy for compounded semaglutide or tirzepatide, with continued follow-up. Current structure and rates live on LifeMD's official website.

What a subscription typically bundles

The appeal of a subscription is that recurring elements are packaged together. In a program like this, an ongoing plan generally folds in the clinical evaluation, the prescription pathway, and follow-up support for dose titration and side-effect management under a single recurring charge, with the medication billed according to the option chosen.

The four-step flow inside the plan

Enrollment usually follows a set sequence: complete an intake covering weight, history, and medications; a clinician reviews eligibility and prescribes; the order routes to a retail or compounding pharmacy; and follow-up care continues. Provider type, pharmacy partner, and billing cadence vary between brands.

Brand-name versus compounded dispensing

A meaningful distinction inside any GLP-1 program is whether the medication is an FDA-approved brand product from a retail pharmacy or a compounded semaglutide or tirzepatide from a licensed 503A pharmacy. The dispensing pathway affects both what you receive and what you pay, and it depends on eligibility and the brand's pharmacy network.

Availability of a given option can also shift with supply conditions and regulatory status, which is why a program may emphasize compounded semaglutide or tirzepatide at one point and brand-name products at another. That variability is one more reason to treat the brand's own site as the live source of truth rather than a fixed expectation you carry in from an older article.

Cost drivers inside a subscription plan

Published pricing appears on LifeMD's own site and depends on the product, the subscription tier, and the dispensing route. Across the telehealth GLP-1 market as of April 2026, typical monthly totals span roughly $200 to $700-plus with wide variance. Confirm current numbers on the brand's site before committing, since they change often.

What the GLP-1 trials established

The pharmacology comes from the compound, not the subscription. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) anchor the class, with a trial record that includes STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints vary, and outcomes differ individually.

The genetic context a subscription doesn't include

A subscription plan does not screen the genetics that shape a GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene targeted by every GLP-1 compound), MC4R, and TCF7L2 describe the metabolic terrain a clinician prescribes into. These pathway-level signals do not predict response to any specific compound, but they add context no subscription captures. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols - Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, the test-before-you-invest step that turns guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with LifeMD and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: GLP-1 Drugs, GLP-1 Hormone, What Is GLP-1, GLP-1 What Is.

Frequently Asked Questions

What does the LifeMD GLP-1 subscription include?

A subscription in this model typically bundles the remote clinical evaluation, the prescription pathway, and ongoing follow-up under a recurring charge, with medication billed by the option selected. Exact inclusions and tiers appear on the brand's own site, which you should verify before enrolling since details change.

Does LifeMD prescribe brand-name or compounded GLP-1 medication?

Depending on eligibility and the pharmacy pathway, a program like this may dispense FDA-approved brand products from a retail pharmacy or compounded semaglutide or tirzepatide from a licensed 503A pharmacy. Confirm which route applies during intake, as it affects both the medication and the price.

How does the Precision Peptide Genetic Test relate to a GLP-1 subscription?

It does not predict how you will respond to any subscription or compound. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 biology, context that remains relevant no matter which telehealth service manages your plan.

How does PlexusDx compare to LifeMD?

PlexusDx pairs its Weight Management Protocols with the Precision Peptide Genetic Test, adding upstream genetic context most subscription programs such as LifeMD do not provide alongside the medication. The differentiator is pathway-level insight, not a judgment about whose subscription is superior.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.